Materials·Commodity Chemicals·$22.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.26 | N/A | -244.44% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.26 | N/A | -244.44% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about the current market environment impacting earnings. They are prioritizing cost control and efficiency improvements.
Management acknowledged the challenging market conditions affecting performance.
They emphasized a focus on cost management and operational efficiency moving forward.
LyondellBasell's disappointing EPS report indicates challenges in the current market, leading to a stock decline of 1.9%. The company did not provide revenue figures or future guidance, which may leave investors uncertain about its direction. Management's focus on cost management suggests they are preparing for continued volatility.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
UNITEDHEALTH GROUP I
Jan 27, 2026